Vapotherm to Participate in the William Blair 42nd Annual Growth Stock Conference

Author's Avatar
Jun 01, 2022

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022.